Today we revisit small oncology concern AVEO Pharmaceuticals after the stock's better-than-15% move on Monday.
We look at the progress the company has made and what may lie ahead for it and its stock.
A full investment analysis on this ~$3 oncology concern is provided in the paragraphs below.
"It's probably my job to tell you life isn't fair, but I figure you already know that. So instead, I'll tell you that hope is precious, and you're right not to give up." - C.J.